# A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure

> **NCT02135861** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 41 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **PROCEDURE:** DCE-MRI scans
- **OTHER:** Gadobutrol

## Key facts

- **NCT ID:** NCT02135861
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-30
- **Primary completion:** 2017-02-22
- **Final completion:** 2017-02-22
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135861, "A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02135861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*